{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:39:09Z","timestamp":1790797149705,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":685,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13311-021-01158-8","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T17:02:26Z","timestamp":1637254946000},"page":"2436-2448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABAA Receptor"],"prefix":"10.1016","volume":"18","author":[{"given":"Wei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokulapriya","family":"Govindarajalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Irungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-3272","authenticated-orcid":false,"given":"Yuan-Xiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-021-01158-8_bib1","doi-asserted-by":"crossref","unstructured":"Mantyh PW (2006) Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7: 797\u2013809. nrn1914. https:\/\/doi.org\/10.1038\/nrn1914.","DOI":"10.1038\/nrn1914"},{"key":"10.1007\/s13311-021-01158-8_bib2","doi-asserted-by":"crossref","unstructured":"Mercadante S (1997) Malignant bone pain: pathophysiology and treatment. Pain 69: 1\u201318. S0304\u20133959(96)03267\u20138.","DOI":"10.1016\/S0304-3959(96)03267-8"},{"key":"10.1007\/s13311-021-01158-8_bib3","doi-asserted-by":"crossref","unstructured":"Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14 Suppl 4: iv45-iv54. nos203. https:\/\/doi.org\/10.1093\/neuonc\/nos203.","DOI":"10.1093\/neuonc\/nos203"},{"key":"10.1007\/s13311-021-01158-8_bib4","doi-asserted-by":"crossref","unstructured":"Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13: 27\u201346. JNS156. https:\/\/doi.org\/10.1111\/j.1529-8027.2008.00156.x.","DOI":"10.1111\/j.1529-8027.2008.00156.x"},{"key":"10.1007\/s13311-021-01158-8_bib5","doi-asserted-by":"crossref","unstructured":"Gaskin DJ, Richard P (2012) The economic costs of pain in the United States. J Pain 13: 715\u2013724. S1526\u20135900(12)00559\u20137. https:\/\/doi.org\/10.1016\/j.jpain.2012.03.009.","DOI":"10.1016\/j.jpain.2012.03.009"},{"key":"10.1007\/s13311-021-01158-8_bib6","doi-asserted-by":"crossref","unstructured":"Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10: 895\u2013926. S1526\u20135900(09)00609\u20139. https:\/\/doi.org\/10.1016\/j.jpain.2009.06.012.","DOI":"10.1016\/j.jpain.2009.06.012"},{"key":"10.1007\/s13311-021-01158-8_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/AJP.0000000000000547","article-title":"A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice","volume":"34","author":"Aiyer","year":"2018","journal-title":"Clin J Pain"},{"key":"10.1007\/s13311-021-01158-8_bib8","doi-asserted-by":"crossref","unstructured":"Park JS, Voitenko N, Petralia RS, Guan X, Xu JT, Steinberg JP, Takamiya K, Sotnik A, Kopach O, Huganir RL, Tao YX (2009) Persistent inflammation induces GluR2 internalization via NMDA receptor-triggered PKC activation in dorsal horn neurons. J Neurosci 29: 3206\u20133219. 29\/10\/3206. https:\/\/doi.org\/10.1523\/JNEUROSCI.4514-08.2009.","DOI":"10.1523\/JNEUROSCI.4514-08.2009"},{"key":"10.1007\/s13311-021-01158-8_bib9","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/00001756-200110290-00022","article-title":"Knockdown of PSD-95\/SAP90 delays the development of neuropathic pain in rats","volume":"12","author":"Tao","year":"2001","journal-title":"Neuroreport"},{"key":"10.1007\/s13311-021-01158-8_bib10","doi-asserted-by":"crossref","unstructured":"Tao YX, Huang YZ, Mei L, Johns RA (2000) Expression of PSD-95\/SAP90 is critical for N-methyl-D-aspartate receptor-mediated thermal hyperalgesia in the spinal cord. Neuroscience 98: 201\u2013206. S0306\u20134522(00)00193\u20137 [pii];https:\/\/doi.org\/10.1016\/s0306-4522(00)00193-7.","DOI":"10.1016\/S0306-4522(00)00193-7"},{"key":"10.1007\/s13311-021-01158-8_bib11","doi-asserted-by":"crossref","unstructured":"Tao YX, Rumbaugh G, Wang GD, Petralia RS, Zhao C, Kauer FW, Tao F, Zhuo M, Wenthold RJ, Raja SN, Huganir RL, Bredt DS, Johns RA (2003) Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 23: 6703\u20136712. 23\/17\/6703.","DOI":"10.1523\/JNEUROSCI.23-17-06703.2003"},{"key":"10.1007\/s13311-021-01158-8_bib12","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2174\/1381612054865082","article-title":"NMDA antagonists and neuropathic pain\u2013multiple drug targets and multiple uses","volume":"11","author":"Chizh","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1007\/s13311-021-01158-8_bib13","doi-asserted-by":"crossref","unstructured":"Parsons CG (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429: 71\u201378. S0014299901013073. https:\/\/doi.org\/10.1016\/s0014-2999(01)01307-3.","DOI":"10.1016\/S0014-2999(01)01307-3"},{"key":"10.1007\/s13311-021-01158-8_bib14","doi-asserted-by":"crossref","unstructured":"Zhou L, Li F, Xu HB, Luo CX, Wu HY, Zhu MM, Lu W, Ji X, Zhou QG, Zhu DY (2010) Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat Med 16: 1439\u20131443. nm.2245. https:\/\/doi.org\/10.1038\/nm.2245.","DOI":"10.1038\/nm.2245"},{"key":"10.1007\/s13311-021-01158-8_bib15","doi-asserted-by":"crossref","unstructured":"Cai W, Wu S, Pan Z, Xiao J, Li F, Cao J, Zang W, Tao YX (2018) Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain. Neuropharmacology 141: 238\u2013248. S0028\u20133908(18)30618-X. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.003.","DOI":"10.1016\/j.neuropharm.2018.09.003"},{"key":"10.1007\/s13311-021-01158-8_bib16","doi-asserted-by":"crossref","unstructured":"Florio SK, Loh C, Huang SM, Iwamaye AE, Kitto KF, Fowler KW, Treiberg JA, Hayflick JS, Walker JM, Fairbanks CA, Lai Y (2009) Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents. Br J Pharmacol 158: 494\u2013506. BPH300. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00300.x.","DOI":"10.1111\/j.1476-5381.2009.00300.x"},{"key":"10.1007\/s13311-021-01158-8_bib17","doi-asserted-by":"crossref","unstructured":"Lee WH, Xu Z, Ashpole NM, Hudmon A, Kulkarni PM, Thakur GA, Lai YY, Hohmann AG (2015) Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics. Neuropharmacology 97: 464\u2013475. S0028\u20133908(15)00228\u20132. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.038.","DOI":"10.1016\/j.neuropharm.2015.05.038"},{"key":"10.1007\/s13311-021-01158-8_bib18","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s13311-020-00883-w","article-title":"Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition","volume":"17","author":"Li","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-021-01158-8_bib19","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.7150\/thno.58364","article-title":"A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and alpha2-containning GABAARs","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1007\/s13311-021-01158-8_bib20","doi-asserted-by":"crossref","unstructured":"Chen D, Zhao T, Ni K, Dai P, Yang L, Xu Y, Li F (2016) Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia. Bioorg Med Chem Lett 26: 2152\u20132155. S0960\u2013894X(16)30306\u20137. https:\/\/doi.org\/10.1016\/j.bmcl.2016.03.074.","DOI":"10.1016\/j.bmcl.2016.03.074"},{"key":"10.1007\/s13311-021-01158-8_bib21","doi-asserted-by":"crossref","unstructured":"Miao XR, Fan LC, Wu S, Mao Q, Li Z, Lutz B, Xu JT, Lu Z, Tao YX (2017) DNMT3a contributes to the development and maintenance of bone cancer pain by silencing Kv1.2 expression in spinal cord dorsal horn. Mol Pain 13: 1744806917740681. https:\/\/doi.org\/10.1177\/1744806917740681.","DOI":"10.1177\/1744806917740681"},{"key":"10.1007\/s13311-021-01158-8_bib22","doi-asserted-by":"crossref","first-page":"10886","DOI":"10.1523\/JNEUROSCI.19-24-10886.1999","article-title":"Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain","volume":"19","author":"Schwei","year":"1999","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-021-01158-8_bib23","doi-asserted-by":"crossref","unstructured":"Zhang RX, Liu B, Wang L, Ren K, Qiao JT, Berman BM, Lao L (2005) Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118: 125\u2013136. S0304\u20133959(05)00383\u20130. https:\/\/doi.org\/10.1016\/j.pain.2005.08.001.","DOI":"10.1016\/j.pain.2005.08.001"},{"key":"10.1007\/s13311-021-01158-8_bib24","doi-asserted-by":"crossref","unstructured":"Mao Q, Wu S, Gu X, Du S, Mo K, Sun L, Cao J, Bekker A, Chen L, Tao YX (2019) DNMT3a-triggered downregulation of K2p 1.1 gene in primary sensory neurons contributes to paclitaxel-induced neuropathic pain. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.32155.","DOI":"10.1002\/ijc.32155"},{"key":"10.1007\/s13311-021-01158-8_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s13311-020-00931-5","article-title":"CREB Participates in Paclitaxel-Induced Neuropathic Pain Genesis Through Transcriptional Activation of Dnmt3a in Primary Sensory Neurons","volume":"18","author":"Yang","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1007\/s13311-021-01158-8_bib26","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1161\/STROKEAHA.121.034173","article-title":"FTO (Fat-Mass and Obesity-Associated Protein) Participates in Hemorrhage-Induced Thalamic Pain by Stabilizing Toll-Like Receptor 4 Expression in Thalamic Neurons","volume":"52","author":"Fu","year":"2021","journal-title":"Stroke"},{"key":"10.1007\/s13311-021-01158-8_bib27","doi-asserted-by":"crossref","first-page":"e2004515","DOI":"10.1002\/advs.202004515","article-title":"Downregulation of a Dorsal Root Ganglion-Specifically Enriched Long Noncoding RNA is Required for Neuropathic Pain by Negatively Regulating RALY-Triggered Ehmt2 Expression","volume":"8","author":"Pan","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1007\/s13311-021-01158-8_bib28","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","article-title":"Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation","volume":"158","author":"Grenald","year":"2017","journal-title":"Pain"},{"key":"10.1007\/s13311-021-01158-8_bib29","doi-asserted-by":"crossref","first-page":"1902402","DOI":"10.1002\/advs.201902402","article-title":"N(6)-Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons","volume":"7","author":"Li","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1007\/s13311-021-01158-8_bib30","doi-asserted-by":"crossref","unstructured":"Zhao JY, Liang L, Gu X, Li Z, Wu S, Sun L, Atianjoh FE, Feng J, Mo K, Jia S, Lutz BM, Bekker A, Nestler EJ, Tao YX (2017) DNA methyltransferase DNMT3a contributes to neuropathic pain by repressing Kcna2 in primary afferent neurons. Nat Commun 8: 14712. ncomms14712. https:\/\/doi.org\/10.1038\/ncomms14712.","DOI":"10.1038\/ncomms14712"},{"key":"10.1007\/s13311-021-01158-8_bib31","doi-asserted-by":"crossref","unstructured":"Zhao X, Tang Z, Zhang H, Atianjoh FE, Zhao JY, Liang L, Wang W, Guan X, Kao SC, Tiwari V, Gao YJ, Hoffman PN, Cui H, Li M, Dong X, Tao YX (2013) A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci 16: 1024\u20131031. nn.3438. https:\/\/doi.org\/10.1038\/nn.3438.","DOI":"10.1038\/nn.3438"},{"key":"10.1007\/s13311-021-01158-8_bib32","doi-asserted-by":"crossref","unstructured":"Carey LM, Lee WH, Gutierrez T, Kulkarni PM, Thakur GA, Lai YY, Hohmann AG (2017) Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats. Neuroscience 349: 303\u2013317. S0306\u20134522(17)30146-X. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.02.055.","DOI":"10.1016\/j.neuroscience.2017.02.055"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01158-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01158-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923007146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01158-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:51:05Z","timestamp":1761807065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923007146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1878747923007146"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01158-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABAA Receptor","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01158-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}